Amesite Announces Proposed Public Offering
Rhea-AI Summary
Amesite Inc (Nasdaq: AMST), an AI technology company focusing on B2C and B2B solutions, has announced plans for a 'best efforts' underwritten public offering of common stock and pre-funded warrants. Laidlaw & Company and Craft Capital Management will serve as joint book-running managers for the offering.
The offering will be conducted under a previously filed and effective shelf registration statement (Form S-3, Registration No. 333-282999) from December 18, 2024. The company plans to use the proceeds for general corporate purposes, capital expenditures, working capital, and administrative expenses.
The final terms, size, and completion of the offering remain subject to market conditions, with no guarantees of completion. A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC.
Positive
- Access to additional capital for corporate operations and growth
- Effective shelf registration statement already in place
- Engagement of established financial institutions as joint book-running managers
Negative
- Potential dilution of existing shareholders' value
- 'Best efforts' basis indicates uncertainty in offering completion
- No specified amount of capital to be raised
- Lack of specific use of proceeds beyond general purposes
News Market Reaction
On the day this news was published, AMST declined 30.86%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
DETROIT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof) in a “best efforts” underwritten public offering. The proposed offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC are acting as joint book-running managers for the offering.
The Company intends to use the net proceeds from the offering for [general corporate purposes, capital expenditures, working capital and general and administrative expenses].
A shelf registration statement on Form S-3 (Registration No. 333-282999) relating to the public offering of the securities described above was previously filed with the Securities and Exchange Commission (SEC) and declared effective on December 18, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the proposed underwritten public offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Copies of the preliminary prospectus supplement (when available) and accompanying prospectus relating to the offering may be obtained from Laidlaw & Company (UK) Ltd., 521 Fifth Ave., 12th Floor, New York, NY 10175, Attention: Syndicate Dept.; email: syndicate@laidlawltd.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.
About Amesite Inc.
Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for health and care professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company’s anticipated public offering, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
FAQ
What is the purpose of Amesite's (AMST) January 2025 public offering?
Who are the underwriters for AMST's 2025 public offering?
What type of securities is AMST offering in January 2025?
When was AMST's shelf registration statement declared effective?
How will this public offering impact AMST shareholders?
